Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease

model of Aβ-associated toxicity, consistent with the mechanism of action identified from the in silico and in vitro studies. These results illustrate the strategy of stabilizing the monomeric states of disordered proteins with small molecules to alter their behavior for therapeutic purposes.

Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease | Litlas